ATE170860T1 - Antibiotische carbapenemverbindungen - Google Patents

Antibiotische carbapenemverbindungen

Info

Publication number
ATE170860T1
ATE170860T1 AT93305608T AT93305608T ATE170860T1 AT E170860 T1 ATE170860 T1 AT E170860T1 AT 93305608 T AT93305608 T AT 93305608T AT 93305608 T AT93305608 T AT 93305608T AT E170860 T1 ATE170860 T1 AT E170860T1
Authority
AT
Austria
Prior art keywords
4alkyl
hydrogen
preparation
carbon atom
group
Prior art date
Application number
AT93305608T
Other languages
English (en)
Inventor
Frederic Henri Jung
Original Assignee
Zeneca Ltd
Zeneca Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd, Zeneca Pharma Sa filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ATE170860T1 publication Critical patent/ATE170860T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT93305608T 1992-07-21 1993-07-16 Antibiotische carbapenemverbindungen ATE170860T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92402104 1992-07-21

Publications (1)

Publication Number Publication Date
ATE170860T1 true ATE170860T1 (de) 1998-09-15

Family

ID=8211690

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93305608T ATE170860T1 (de) 1992-07-21 1993-07-16 Antibiotische carbapenemverbindungen

Country Status (7)

Country Link
US (1) US5444057A (de)
JP (1) JPH06179675A (de)
KR (1) KR100278030B1 (de)
AT (1) ATE170860T1 (de)
CA (1) CA2099811A1 (de)
DE (1) DE69320896T2 (de)
ES (1) ES2121058T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CN101613352B (zh) * 2008-06-25 2013-03-27 山东轩竹医药科技有限公司 含有甲酰胺杂环基巯基吡咯烷的培南衍生物
KR20160114385A (ko) 2015-03-24 2016-10-05 이경욱 소음 방지 구조
WO2017157396A1 (en) * 2016-03-13 2017-09-21 Tina Hetting Holding Aps An injector with reduced break loose force

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
JPS55132593A (en) * 1979-04-02 1980-10-15 Fujitsu Ltd Refresh control method for memory unit
JPS55144190U (de) * 1979-04-05 1980-10-16
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
CA1281720C (en) * 1984-11-08 1991-03-19 Makoto Sunagawa Carbapenem compounds and production thereof
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
AU646012B2 (en) * 1990-02-23 1994-02-03 Sankyo Company Limited Carbapenem derivatives having antibiotic activity, their preparation and their use
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds

Also Published As

Publication number Publication date
CA2099811A1 (en) 1994-01-22
DE69320896D1 (de) 1998-10-15
KR940002245A (ko) 1994-02-17
US5444057A (en) 1995-08-22
JPH06179675A (ja) 1994-06-28
ES2121058T3 (es) 1998-11-16
DE69320896T2 (de) 1999-01-28
KR100278030B1 (ko) 2001-02-01

Similar Documents

Publication Publication Date Title
MY111685A (en) Antibiotic compounds.
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
ATE170859T1 (de) Antibiotische carbapenemverbindungen
GB9107341D0 (en) Antibiotic compounds
CA2108356A1 (en) Antibiotic compounds
ATE179978T1 (de) Carbapenemverbindungen als antibiotika
CA2155493A1 (en) Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
ES8800683A1 (es) Un procedimiento para la preparacion de nuevos derivados penem
IE790630L (en) 2, 6-dialkoxybenzamido-pyrrolidines.
ATE170860T1 (de) Antibiotische carbapenemverbindungen
ES2123031T3 (es) Compuestos antibioticos de carbapenem.
DE3166235D1 (en) Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
DE69327380D1 (de) Antibiotische Pyrrolidinylthiopenemderivate
ES8403488A1 (es) Un procedimiento para la preparacion de antibioticos b-lactamicos.
AU2002211006A1 (en) Novel beta-lactam compounds and proecss for producing the same
ES8707951A1 (es) Derivados de tetrazol
ES2144446T3 (es) Compuestos de carbapenem antibioticos.
IE820238L (en) Carbapenem derivatives
JO1777B1 (en) Compounds used as antibiotics
CA2129813A1 (en) 5-aminoflavone derivatives
EP0059554A3 (de) Beta-Lactam-Antibiotika, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
YU59093A (sh) Antibiotička jedinjenja
JO1672B1 (en) Dialoxy-pyridinyl-benzimidazole derivatives and a way to prepare and use it in a pharmacy
JO1740B1 (en) Antibiotic compounds
RU93058363A (ru) Антибиотические соединения, способ их получения, фармацевтическая композиция, способ лечения, промежуточные продукты и способ их получения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties